These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2705261)

  • 1. The relative effects of aztreonam versus gentamicin on nephrotoxicity induced by warm ischemia in the presence and absence of cyclosporine.
    Erturk E; Bretan P; Pestana J; Steinmuller D; Stowe NT; Novick AC
    Transplant Proc; 1989 Feb; 21(1 Pt 1):932-3. PubMed ID: 2705261
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear magnetic resonance and biochemical studies to determine the synergistic detrimental effects of renal ischemia on cyclosporine nephrotoxicity in the rat.
    Chan L; Suleymanlar G; Malhotra D; Lien YH; Shapiro JI
    Transplant Proc; 1991 Feb; 23(1 Pt 1):711-3. PubMed ID: 1990660
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitochondrial alterations after cyclosporine and ischemia: insights on the pathophysiology of nephrotoxicity.
    Khauli RB; Strzelecki T; Kumar S; Fink M; Stoff J; Menon M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1395-7. PubMed ID: 3274339
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute nephrotoxicity following intravenous cyclosporine.
    Hirsch S; Besarab A; Jarrell BE; Carabasi RA; Cressman MD; Green P
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1387-90. PubMed ID: 3824501
    [No Abstract]   [Full Text] [Related]  

  • 5. Deleterious effect of cyclosporines on the ischemic kidney in the rat and protection by the calcium antagonist verapamil.
    Ar'Rajab A; Dawidson IJ; Sentementes JT; Harris RB
    Transplant Proc; 1994 Oct; 26(5):2894-5. PubMed ID: 7940914
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe nephrotoxicity caused by the combined use of gentamicin and cyclosporine in renal allograft recipients.
    Termeer A; Hoitsma AJ; Koene RA
    Transplantation; 1986 Aug; 42(2):220-1. PubMed ID: 3526659
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental cyclosporine nephrotoxicity: risk of concomitant chemotherapy.
    Ryffel B; Müller AM; Mihatsch MJ
    Clin Nephrol; 1986; 25 Suppl 1():S121-5. PubMed ID: 3708922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in renal blood flow and kidney function by modulation of prostaglandin metabolism in cyclosporine-treated animals.
    Teraoka S; Takahashi K; Tanabe K; Yamaguchi Y; Kawai T; Tojinbara T; Nakajima I; Nakagawa Y; Fujikawa H; Hayashi T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):937-40. PubMed ID: 2784912
    [No Abstract]   [Full Text] [Related]  

  • 9. Beneficial effects of renal denervation and prazosin on GFR and renal blood flow after cyclosporine in rats.
    Murray BM; Paller MS
    Clin Nephrol; 1986; 25 Suppl 1():S37-9. PubMed ID: 3708934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity of cyclosporine G and A in the Sprague-Dawley rat.
    Duncan JI; Simpson JG; Thomson AW; Whiting PH
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1391-2. PubMed ID: 3274338
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenesis of cyclosporine nephrotoxicity.
    Humes HD; Jackson N
    Dev Toxicol Environ Sci; 1986; 14():117-21. PubMed ID: 3829970
    [No Abstract]   [Full Text] [Related]  

  • 12. What is cyclosporine nephrotoxicity?
    Myers BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1430-2. PubMed ID: 2652460
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine A directly constricts intrarenal arterioles.
    Abraham JS; Bentley FR; Garrison RN; Cryer HM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):356-9. PubMed ID: 1990551
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations in renal structure and function in a rat model of cyclosporine nephrotoxicity.
    Jackson NM; Hsu CH; Visscher GE; Venkatachalam MA; Humes HD
    J Pharmacol Exp Ther; 1987 Aug; 242(2):749-56. PubMed ID: 3612560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on nephrotoxicity of cyclosporine in human renal allograft and rat.
    Morozumi K; Shinmura I; Gotoh I; Yoshida A; Fujinami T; Uchida K; Yamada N; Tominaga Y; Nakanishi Y; Kanoh T
    Dev Toxicol Environ Sci; 1986; 14():153-6. PubMed ID: 3549247
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine related hypertension and nephrotoxicity in rat heart transplantation.
    Kanehira A; Shida T; Nakamura H; Wakita N; Ito H; Nakamura K
    Dev Toxicol Environ Sci; 1986; 14():141-7. PubMed ID: 3549246
    [No Abstract]   [Full Text] [Related]  

  • 17. Responses of renal cortical mitochondria to cyclosporine following warm ischemia and cold preservation.
    Khauli RB; Strzelecki T; McGraw B; Takayama T; Laxmanan S; Diamond D; Menon M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1258-60. PubMed ID: 2652414
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephrotoxicity of cyclosporine A in rats with a diminished renal function.
    Provoost AP; Kaptein L; Van Aken M
    Clin Nephrol; 1986; 25 Suppl 1():S162-7. PubMed ID: 3519023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition or aldosterone antagonism reduces cyclosporine nephrotoxicity in the rat.
    Thomson AW; McAuley FT; Whiting PH; Simpson JG
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1242-3. PubMed ID: 2856270
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential contribution of lysosomal proteases to cyclosporine-A-induced nephrotoxicity.
    Olbricht CJ; Gröne HJ; Gutjahr E; Bossaller C
    Toxicol Lett; 1990 Sep; 53(1-2):251-2. PubMed ID: 2219178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.